TRIFLURIDINE

TRIFLURIDINE was reported 10823 times

TRIFLURIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ORTHOPOX VIRUS INFECTION 1 0.1429
1 REMOVAL OF INERT MATTER FROM SKIN OR SUBCUTANEOUS TISSUE 1 0.0667
2 VOMITING PSYCHOGENIC 1 0.0476
3 MESENTERIC FIBROSIS 1 0.0455
4 CLONAL HAEMATOPOIESIS 3 0.0390
5 DEATH OF COMPANION 1 0.0385
6 PASSIVE SMOKING 1 0.0370
7 POSTOPERATIVE RESPIRATORY FAILURE 3 0.0288
8 KERATITIS VIRAL 1 0.0244
9 CARCINOEMBRYONIC ANTIGEN DECREASED 1 0.0238
10 METASTASES TO BILIARY TRACT 1 0.0238
11 SUBDURAL ABSCESS 1 0.0217
12 HERPES SIMPLEX OPHTHALMIC 1 0.0200
13 NEUROTROPHIC KERATOPATHY 1 0.0185
14 OPHTHALMIC HERPES SIMPLEX 8 0.0139
15 COLORECTAL CANCER METASTATIC 31 0.0131
16 STOMAL VARICES 1 0.0122
17 DRUG METABOLITE LEVEL HIGH 1 0.0119
18 MONKEYPOX 3 0.0109
19 RECTAL ADENOCARCINOMA 6 0.0099
20 EYE INFECTION VIRAL 3 0.0093
21 RECTAL CANCER METASTATIC 3 0.0086
22 PSYCHIATRIC EVALUATION 1 0.0085
23 TRAUMATIC FRACTURE 5 0.0068
24 GLOMERULAR VASCULAR DISORDER 1 0.0067
25 PERITONSILLAR ABSCESS 5 0.0060
26 ADENOCARCINOMA OF COLON 11 0.0059
27 PELVIC NEOPLASM 2 0.0058
28 INTESTINAL HAEMATOMA 1 0.0057
29 VASCULAR GRAFT COMPLICATION 1 0.0054
30 ACANTHAMOEBA INFECTION 1 0.0053
31 CHEST WALL ABSCESS 1 0.0051
32 CELLULITIS STAPHYLOCOCCAL 3 0.0046
33 CHOLELITHOTOMY 1 0.0046
34 SOMATOFORM DISORDER 1 0.0046
35 INTUSSUSCEPTION 4 0.0042
36 MUCOSAL TOXICITY 1 0.0037
37 RESORPTION BONE INCREASED 3 0.0037
38 COLON CANCER RECURRENT 1 0.0036
39 CORNEAL INFILTRATES 1 0.0032
40 NEPHROSTOMY 1 0.0030
41 DILATED CARDIOMYOPATHY 3 0.0030
42 PTERYGIUM 1 0.0029
43 DRUG-GENETIC INTERACTION 1 0.0028
44 INSULIN AUTOIMMUNE SYNDROME 1 0.0028
45 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
46 VASCULAR GRAFT OCCLUSION 1 0.0026
47 PARONYCHIA 11 0.0025
48 METASTASES TO THE MEDIASTINUM 1 0.0024
49 RECTAL TENESMUS 3 0.0024
50 PERINEAL ABSCESS 1 0.0022
51 GASTROINTESTINAL STENOSIS 1 0.0022
52 BODY MASS INDEX DECREASED 1 0.0022
53 MICROANGIOPATHY 2 0.0021
54 PROTEIN-LOSING GASTROENTEROPATHY 1 0.0020
55 CORNEAL SCAR 1 0.0020
56 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
57 PERIORBITAL CELLULITIS 1 0.0019
58 SCIATIC NERVE NEUROPATHY 1 0.0019
59 THERAPY PARTIAL RESPONDER 28 0.0018
60 CATHETER SITE INFLAMMATION 1 0.0018
61 RENAL TUBULAR DYSFUNCTION 1 0.0018
62 EYE ULCER 1 0.0017
63 CORNEAL EPITHELIUM DEFECT 1 0.0017
64 COLON CANCER STAGE IV 1 0.0017
65 HYPERTRICHOSIS 3 0.0016
66 DRY GANGRENE 1 0.0016
67 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
68 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
69 KLEBSIELLA TEST POSITIVE 1 0.0015
70 GENE MUTATION 3 0.0015
71 GASTROINTESTINAL TOXICITY 7 0.0015
72 NEUROENDOCRINE CARCINOMA 1 0.0014
73 PRODUCT LEAKAGE 8 0.0014
74 INTESTINAL FISTULA 2 0.0014
75 CORNEAL DEPOSITS 1 0.0013
76 BRONCHITIS BACTERIAL 1 0.0013
77 RECTAL CANCER 4 0.0013
78 PRODUCT DROPPER ISSUE 1 0.0013
79 MAMMOPLASTY 1 0.0013
80 COLON CANCER METASTATIC 2 0.0012
81 SPUTUM CULTURE POSITIVE 1 0.0012
82 HYPERPARATHYROIDISM SECONDARY 3 0.0012
83 ABSCESS DRAINAGE 1 0.0012
84 ABDOMINAL LYMPHADENOPATHY 1 0.0012
85 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
86 FANCONI SYNDROME ACQUIRED 2 0.0011
87 HILAR LYMPHADENOPATHY 1 0.0011
88 DRUG DETOXIFICATION 1 0.0011
89 CATHETER MANAGEMENT 1 0.0011
90 OROPHARYNGEAL CANDIDIASIS 1 0.0011
91 RASH PUSTULAR 8 0.0011
92 METASTASES TO ADRENALS 1 0.0011
93 POOR QUALITY DRUG ADMINISTERED 7 0.0011
94 CATHETER SITE SWELLING 1 0.0011
95 KLEBSIELLA BACTERAEMIA 1 0.0011
96 ACTINOMYCOSIS 1 0.0010
97 RECTAL POLYP 1 0.0010
98 MESENTERIC VEIN THROMBOSIS 1 0.0010
99 POLYNEUROPATHY 12 0.0010
100 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
101 HYPOGONADISM 1 0.0010
102 PATHOGEN RESISTANCE 9 0.0010
103 FULMINANT TYPE 1 DIABETES MELLITUS 1 0.0010
104 METASTASES TO PLEURA 1 0.0010
105 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
106 INNER EAR DISORDER 1 0.0009
107 CORNEAL DISORDER 2 0.0009
108 SOFT TISSUE DISORDER 1 0.0009
109 HALO VISION 1 0.0009
110 SKIN TOXICITY 5 0.0009
111 PELVIC ABSCESS 1 0.0009
112 METASTASES TO LUNG 10 0.0009
113 LIP ULCERATION 1 0.0009
114 DERMATITIS ACNEIFORM 5 0.0008
115 CEREBRAL ARTERY EMBOLISM 1 0.0008
116 TOOTH EROSION 1 0.0008
117 HELICOBACTER GASTRITIS 1 0.0008
118 RENAL ATROPHY 1 0.0008
119 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
120 TUMOUR PAIN 1 0.0008
121 HERPES OPHTHALMIC 1 0.0008
122 HAEMATOTOXICITY 7 0.0007
123 SIALOADENITIS 1 0.0007
124 CARBON DIOXIDE INCREASED 1 0.0007
125 CORNEAL OPACITY 1 0.0007
126 CALCULUS BLADDER 1 0.0007
127 NEPHROTIC SYNDROME 5 0.0007
128 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
129 FANCONI SYNDROME 1 0.0007
130 NEUROTOXICITY 12 0.0007
131 ANKLE OPERATION 1 0.0007
132 HEART VALVE REPLACEMENT 1 0.0007
133 ADHESION 1 0.0007
134 DRUG RESISTANCE 17 0.0007
135 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
136 STOMA SITE HAEMORRHAGE 1 0.0006
137 OSTEOMALACIA 1 0.0006
138 FUNGAEMIA 1 0.0006
139 KERATOPATHY 1 0.0006
140 METASTASES TO LIVER 11 0.0006
141 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
142 CYSTITIS INTERSTITIAL 1 0.0006
143 IGA NEPHROPATHY 1 0.0006
144 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
145 ARTHROPOD STING 1 0.0006
146 ENTEROBACTER INFECTION 1 0.0006
147 PATHOLOGICAL FRACTURE 3 0.0006
148 TREATMENT DELAYED 1 0.0006
149 EYE DISCHARGE 6 0.0006
150 DEFAECATION URGENCY 4 0.0006
151 BURNS SECOND DEGREE 1 0.0006
152 JUGULAR VEIN THROMBOSIS 1 0.0006
153 X-RAY ABNORMAL 1 0.0006
154 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
155 PHOTOSENSITIVITY REACTION 9 0.0005
156 VIRAL MUTATION IDENTIFIED 2 0.0005
157 STENOSIS 1 0.0005
158 OCULAR HYPERTENSION 1 0.0005
159 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
160 OCCULT BLOOD POSITIVE 1 0.0005
161 JOINT CREPITATION 1 0.0005
162 EMPYEMA 1 0.0005
163 EYELID PAIN 1 0.0005
164 MICROCYTIC ANAEMIA 1 0.0005
165 EYE PAIN 27 0.0005
166 PHOTOPHOBIA 9 0.0005
167 CATHETER SITE ERYTHEMA 1 0.0005
168 GASTRIC CANCER STAGE IV 1 0.0005
169 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
170 INCORRECT PRODUCT STORAGE 6 0.0005
171 CORNEAL OEDEMA 1 0.0004
172 METASTASES TO LYMPH NODES 3 0.0004
173 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
174 VASCULAR DEVICE INFECTION 2 0.0004
175 DERMATITIS CONTACT 5 0.0004
176 READING DISORDER 1 0.0004
177 BREAKTHROUGH PAIN 1 0.0004
178 NEPHROGENIC ANAEMIA 2 0.0004
179 ORAL SURGERY 1 0.0004
180 THERMAL BURN 3 0.0004
181 PUSTULE 1 0.0004
182 METASTASIS 3 0.0004
183 SINUS OPERATION 1 0.0004
184 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
185 SYSTEMIC CANDIDA 1 0.0004
186 METASTASES TO PERITONEUM 1 0.0004
187 KLEBSIELLA INFECTION 2 0.0004
188 ACIDOSIS 3 0.0004
189 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
190 CATHETER SITE PAIN 1 0.0004
191 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
192 AREFLEXIA 1 0.0004
193 STENT PLACEMENT 3 0.0004
194 BLOOD PHOSPHORUS INCREASED 1 0.0004
195 RHINALGIA 1 0.0004
196 RENAL TUBULAR DISORDER 1 0.0004
197 OXYGEN SATURATION ABNORMAL 1 0.0004
198 TUMOUR HAEMORRHAGE 1 0.0004
199 PRODUCT CONTAINER ISSUE 3 0.0003
200 DUODENAL ULCER HAEMORRHAGE 1 0.0003
201 EYE IRRITATION 20 0.0003
202 CATARACT OPERATION 2 0.0003
203 HIV INFECTION 1 0.0003
204 KERATITIS 1 0.0003
205 DYSAESTHESIA 1 0.0003
206 PORTAL HYPERTENSION 1 0.0003
207 EYE SWELLING 12 0.0003
208 FAMILY STRESS 1 0.0003
209 BLOOD CREATININE DECREASED 1 0.0003
210 PRODUCT PACKAGING ISSUE 3 0.0003
211 MUCOSAL INFLAMMATION 8 0.0003
212 LISTLESS 1 0.0003
213 OTITIS MEDIA 1 0.0003
214 CEREBRAL HAEMATOMA 1 0.0003
215 HEPATIC CYST 1 0.0003
216 ABNORMAL LOSS OF WEIGHT 2 0.0003
217 ENCEPHALITIS 2 0.0003
218 FOLLICULITIS 3 0.0003
219 JAUNDICE CHOLESTATIC 1 0.0003
220 FACIAL BONES FRACTURE 1 0.0003
221 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
222 FOOD INTOLERANCE 1 0.0003
223 ALCOHOL USE 1 0.0003
224 CONJUNCTIVITIS 5 0.0003
225 INTESTINAL PERFORATION 3 0.0003
226 HYDRONEPHROSIS 2 0.0003
227 PROTEINURIA 5 0.0003
228 TONGUE OEDEMA 1 0.0003
229 GINGIVAL DISORDER 1 0.0003
230 PRESCRIBED OVERDOSE 5 0.0003
231 NICOTINE DEPENDENCE 2 0.0003
232 SKIN FISSURES 5 0.0003
233 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
234 AZOTAEMIA 1 0.0003
235 VITAMIN B12 DEFICIENCY 1 0.0002
236 SHOCK HAEMORRHAGIC 2 0.0002
237 EMBOLISM 2 0.0002
238 GASTROINTESTINAL PERFORATION 1 0.0002
239 ABNORMAL SENSATION IN EYE 1 0.0002
240 HEPATIC LESION 1 0.0002
241 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
242 IRON DEFICIENCY 1 0.0002
243 NEUTROPENIA 30 0.0002
244 IMPAIRED GASTRIC EMPTYING 3 0.0002
245 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
246 SPINAL COLUMN STENOSIS 1 0.0002
247 SKIN ABRASION 1 0.0002
248 OCULAR HYPERAEMIA 10 0.0002
249 EYE INFLAMMATION 2 0.0002
250 TUMOUR MARKER INCREASED 1 0.0002
251 STAPHYLOCOCCAL SEPSIS 1 0.0002
252 ABDOMINAL TENDERNESS 1 0.0002
253 NEUROPATHY PERIPHERAL 19 0.0002
254 ECONOMIC PROBLEM 3 0.0002
255 EYELID PTOSIS 2 0.0002
256 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
257 CACHEXIA 1 0.0002
258 MYELOSUPPRESSION 7 0.0002
259 SKIN NECROSIS 1 0.0002
260 ANAL FISTULA 1 0.0002
261 STRESS FRACTURE 1 0.0002
262 CHEILITIS 1 0.0002
263 ERYTHEMA OF EYELID 1 0.0002
264 CHRONIC KIDNEY DISEASE 14 0.0002
265 ASTHENOPIA 1 0.0002
266 DRUG LEVEL INCREASED 3 0.0002
267 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
268 LEUKOPENIA 9 0.0002
269 OCULAR DISCOMFORT 2 0.0002
270 THERAPY NON-RESPONDER 8 0.0002
271 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
272 DISEASE PROGRESSION 21 0.0002
273 EYE INFECTION 2 0.0002
274 CARDIAC VALVE DISEASE 1 0.0002
275 EYELID OEDEMA 2 0.0002
276 ASCITES 5 0.0002
277 ENERGY INCREASED 1 0.0002
278 BACTERAEMIA 2 0.0002
279 ENDOPHTHALMITIS 1 0.0002
280 HEPATITIS B 1 0.0002
281 END STAGE RENAL DISEASE 3 0.0002
282 ILEUS 2 0.0002
283 SWELLING OF EYELID 1 0.0002
284 BRAIN OEDEMA 2 0.0002
285 INCREASED APPETITE 3 0.0002
286 FOREIGN BODY SENSATION IN EYES 1 0.0002
287 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
288 CARDIAC FLUTTER 1 0.0002
289 PLATELET COUNT INCREASED 2 0.0002
290 SOMNAMBULISM 1 0.0002
291 ANHEDONIA 4 0.0002
292 EYE DISORDER 5 0.0002
293 BREAST MASS 1 0.0001
294 EYE PRURITUS 5 0.0001
295 PRODUCT ADMINISTRATION ERROR 3 0.0001
296 COLITIS ISCHAEMIC 1 0.0001
297 SKIN LESION 4 0.0001
298 ONYCHOCLASIS 1 0.0001
299 DROOLING 1 0.0001
300 LARGE INTESTINE PERFORATION 1 0.0001
301 ORAL DISCOMFORT 2 0.0001
302 HERPES ZOSTER 8 0.0001
303 MAJOR DEPRESSION 1 0.0001
304 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
305 SENSITIVE SKIN 1 0.0001
306 HYPOPHOSPHATAEMIA 1 0.0001
307 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
308 TRANSAMINASES INCREASED 3 0.0001
309 RASH MACULO-PAPULAR 3 0.0001
310 HAEMORRHAGE INTRACRANIAL 2 0.0001
311 HALLUCINATION 10 0.0001
312 LACRIMATION INCREASED 4 0.0001
313 BLOOD COUNT ABNORMAL 2 0.0001
314 OSTEOPENIA 2 0.0001
315 LIPASE INCREASED 1 0.0001
316 HYPOALBUMINAEMIA 1 0.0001
317 PELVIC FRACTURE 1 0.0001
318 PRODUCT STORAGE ERROR 11 0.0001
319 BLOOD DISORDER 1 0.0001
320 FRUSTRATION TOLERANCE DECREASED 1 0.0001
321 METASTASES TO BONE 2 0.0001
322 HICCUPS 1 0.0001
323 SECOND PRIMARY MALIGNANCY 1 0.0001
324 SENSATION OF FOREIGN BODY 1 0.0001
325 CARDIOVASCULAR DISORDER 3 0.0001
326 INADEQUATE ANALGESIA 1 0.0001
327 MUSCLE STRAIN 1 0.0001
328 LUNG INFILTRATION 1 0.0001
329 RENAL FAILURE 15 0.0001
330 CARDIOTOXICITY 1 0.0001
331 FACIAL PAIN 1 0.0001
332 GOUT 2 0.0001
333 OSTEOMYELITIS 2 0.0001
334 RESTLESS LEGS SYNDROME 2 0.0001
335 IRON DEFICIENCY ANAEMIA 1 0.0001
336 PERSONALITY CHANGE 1 0.0001
337 FEBRILE NEUTROPENIA 7 0.0001
338 ACNE 8 0.0001
339 SPUTUM DISCOLOURED 1 0.0001
340 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
341 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
342 VITAMIN D DEFICIENCY 1 0.0001
343 SINUS DISORDER 2 0.0001
344 HAEMATOCRIT DECREASED 2 0.0001
345 SALIVARY HYPERSECRETION 1 0.0001
346 ANAEMIA 19 0.0001
347 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
348 EMPHYSEMA 1 0.0001
349 STOMATITIS 6 0.0001
350 EAR DISCOMFORT 1 0.0001
351 CARDIO-RESPIRATORY ARREST 4 0.0001
352 PRODUCT ODOUR ABNORMAL 1 0.0001
353 TRANSFUSION 1 0.0001
354 SCRATCH 1 0.0001
355 RENAL PAIN 1 0.0001
356 BIPOLAR DISORDER 1 0.0001
357 PULMONARY THROMBOSIS 1 0.0001
358 ASPIRATION 1 0.0001
359 COVID-19 16 0.0001
360 DENTAL CARIES 1 0.0001
361 VISUAL ACUITY REDUCED 3 0.0001
362 VIRAL INFECTION 3 0.0001
363 URINARY RETENTION 3 0.0001
364 SKIN INFECTION 1 0.0001
365 IMPAIRED DRIVING ABILITY 1 0.0001
366 SCAB 1 0.0001
367 VISION BLURRED 12 0.0001
368 NEOPLASM 1 0.0001
369 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
370 NEOPLASM PROGRESSION 3 0.0001
371 ELECTROLYTE IMBALANCE 1 0.0001
372 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
373 DISEASE RECURRENCE 4 0.0001
374 HYPERLIPIDAEMIA 1 0.0001
375 WRIST FRACTURE 1 0.0001
376 HEPATITIS C 1 0.0001
377 NEURALGIA 2 0.0001
378 SMALL INTESTINAL OBSTRUCTION 1 0.0001
379 GENERALISED OEDEMA 1 0.0001
380 INTRAOCULAR PRESSURE INCREASED 1 0.0001
381 ANAPHYLACTIC SHOCK 2 0.0001
382 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
383 HIATUS HERNIA 1 0.0001
384 DEAFNESS 2 0.0001
385 PANCREATITIS 4 0.0001
386 HYPERTENSION 16 0.0001
387 BLOOD BILIRUBIN INCREASED 2 0.0001
388 BLINDNESS 3 0.0001
389 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
390 PERIPHERAL COLDNESS 1 0.0001
391 DIARRHOEA 47 0.0001
392 HAEMOPTYSIS 2 0.0001
393 THROMBOCYTOPENIA 8 0.0001
394 DEVICE OCCLUSION 1 0.0001
395 BLINDNESS UNILATERAL 1 0.0001
396 TARDIVE DYSKINESIA 2 0.0001
397 DIALYSIS 1 0.0001
398 RECTAL HAEMORRHAGE 3 0.0001
399 INJECTION SITE HAEMATOMA 1 0.0001
400 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
401 GASTROENTERITIS 1 0.0001
402 PULMONARY MASS 1 0.0001
403 COLON CANCER 1 0.0001
404 CONDITION AGGRAVATED 20 0.0001
405 PLEURAL EFFUSION 4 0.0001
406 PHARYNGEAL OEDEMA 1 0.0001
407 HYPOKALAEMIA 3 0.0001
408 NERVOUS SYSTEM DISORDER 2 0.0001
409 PRODUCT USE COMPLAINT 1 0.0001
410 ULCER 1 0.0001
411 COLORECTAL CANCER 3 0.0001
412 OBESITY 1 0.0001
413 ABSCESS 1 0.0001
414 SENSORY DISTURBANCE 1 0.0001
415 MULTIPLE FRACTURES 1 0.0001
416 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
417 RENAL IMPAIRMENT 5 0.0001
418 CANDIDA INFECTION 1 0.0001
419 HEMIPARESIS 1 0.0001
420 CIRCULATORY COLLAPSE 1 0.0001
421 MUSCULOSKELETAL PAIN 3 0.0001
422 HYPERKALAEMIA 2 0.0001
423 LYMPHADENOPATHY 2 0.0001
424 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
425 DISTURBANCE IN ATTENTION 3 0.0001
426 PELVIC PAIN 1 0.0001
427 BONE DISORDER 1 0.0001
428 DYSURIA 2 0.0001
429 PANCYTOPENIA 3 0.0001
430 BACTERIAL INFECTION 1 0.0001
431 COLITIS 2 0.0001
432 DEHYDRATION 7 0.0001
433 HERNIA 1 0.0001
434 ATRIAL FIBRILLATION 5 0.0001
435 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
436 ORAL HERPES 1 0.0001
437 UPPER LIMB FRACTURE 1 0.0001
438 PRODUCT PHYSICAL ISSUE 1 0.0000
439 EMOTIONAL DISTRESS 6 0.0000
440 BODY TEMPERATURE INCREASED 1 0.0000
441 OSTEOPOROSIS 2 0.0000
442 RIB FRACTURE 1 0.0000
443 TOOTH LOSS 1 0.0000
444 TOXICITY TO VARIOUS AGENTS 8 0.0000
445 HALLUCINATION, VISUAL 1 0.0000
446 IRRITABLE BOWEL SYNDROME 1 0.0000
447 PRODUCT PRESCRIBING ISSUE 1 0.0000
448 ACUTE KIDNEY INJURY 7 0.0000
449 APPLICATION SITE PAIN 1 0.0000
450 DEATH 39 0.0000
451 LIVER DISORDER 2 0.0000
452 INSOMNIA 12 0.0000
453 VOMITING 21 0.0000
454 ADVERSE EVENT 4 0.0000
455 DECREASED APPETITE 10 0.0000
456 RENAL DISORDER 2 0.0000
457 BLOOD CHOLESTEROL INCREASED 2 0.0000
458 BURNING SENSATION 3 0.0000
459 THERAPY INTERRUPTED 3 0.0000
460 DRUG INTOLERANCE 4 0.0000
461 CONSTIPATION 9 0.0000
462 INJECTION SITE URTICARIA 1 0.0000
463 LIVER INJURY 1 0.0000
464 EXTRAPYRAMIDAL DISORDER 1 0.0000
465 HYPOAESTHESIA 6 0.0000
466 DRY EYE 2 0.0000
467 DEPRESSION 9 0.0000
468 PRODUCT COMPLAINT 1 0.0000
469 HAEMATEMESIS 1 0.0000
470 WEIGHT DECREASED 11 0.0000
471 ERECTILE DYSFUNCTION 1 0.0000
472 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
473 INFLAMMATION 2 0.0000
474 ABDOMINAL PAIN 9 0.0000
475 SKIN ULCER 1 0.0000
476 EXPOSURE VIA SKIN CONTACT 1 0.0000
477 JOINT STIFFNESS 1 0.0000
478 GASTRITIS 1 0.0000
479 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
480 DRY SKIN 5 0.0000
481 CARDIAC FAILURE 3 0.0000
482 FEAR 1 0.0000
483 PNEUMONIA 12 0.0000
484 THROAT TIGHTNESS 1 0.0000
485 LIMB INJURY 1 0.0000
486 NAUSEA 29 0.0000
487 DRUG INEFFECTIVE 48 0.0000
488 MENTAL STATUS CHANGES 1 0.0000
489 NECK PAIN 2 0.0000
490 DEMENTIA 1 0.0000
491 HYPONATRAEMIA 2 0.0000
492 ANGINA PECTORIS 1 0.0000
493 MUSCULOSKELETAL STIFFNESS 3 0.0000
494 DYSPHONIA 2 0.0000
495 WHEEZING 2 0.0000
496 RENAL INJURY 1 0.0000
497 BLOOD POTASSIUM DECREASED 1 0.0000
498 CORONARY ARTERY DISEASE 1 0.0000
499 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
500 EMOTIONAL DISORDER 1 0.0000
501 CHEST PAIN 6 0.0000
502 FATIGUE 25 0.0000
503 CARDIAC DISORDER 3 0.0000
504 BONE DENSITY DECREASED 1 0.0000
505 HEAD INJURY 1 0.0000
506 CYSTITIS 1 0.0000
507 HYPOTHYROIDISM 1 0.0000
508 MOVEMENT DISORDER 1 0.0000
509 NIGHT SWEATS 1 0.0000
510 PAIN 19 0.0000
511 DEEP VEIN THROMBOSIS 2 0.0000
512 SWELLING FACE 2 0.0000
513 DYSPEPSIA 3 0.0000
514 IMPAIRED HEALING 1 0.0000
515 OSTEONECROSIS 1 0.0000
516 BACK PAIN 7 0.0000
517 FUNGAL INFECTION 1 0.0000
518 TYPE 2 DIABETES MELLITUS 1 0.0000
519 ANGER 1 0.0000
520 RASH MACULAR 1 0.0000
521 HEART RATE DECREASED 1 0.0000
522 INJURY 2 0.0000
523 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
524 ANXIETY 8 0.0000
525 C-REACTIVE PROTEIN INCREASED 1 0.0000
526 PANIC ATTACK 1 0.0000
527 RESTLESSNESS 1 0.0000
528 PRODUCT DOSE OMISSION ISSUE 8 0.0000
529 HYPERSENSITIVITY 5 0.0000
530 HEPATIC FUNCTION ABNORMAL 1 0.0000
531 INTESTINAL OBSTRUCTION 1 0.0000
532 UNEVALUABLE EVENT 2 0.0000
533 OFF LABEL USE 23 0.0000
534 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
535 PALPITATIONS 3 0.0000
536 ABNORMAL BEHAVIOUR 1 0.0000
537 CARDIAC FAILURE CONGESTIVE 2 0.0000
538 EXTRA DOSE ADMINISTERED 1 0.0000
539 OEDEMA PERIPHERAL 3 0.0000
540 NEUTROPHIL COUNT DECREASED 1 0.0000
541 VISUAL IMPAIRMENT 3 0.0000
542 TREATMENT FAILURE 2 0.0000
543 DIZZINESS 12 0.0000
544 ROAD TRAFFIC ACCIDENT 1 0.0000
545 OSTEOARTHRITIS 1 0.0000
546 BALANCE DISORDER 2 0.0000
547 DEVICE DISLOCATION 1 0.0000
548 SEPTIC SHOCK 1 0.0000
549 MENTAL DISORDER 1 0.0000
550 THROAT IRRITATION 1 0.0000
551 PRODUCT QUALITY ISSUE 3 0.0000
552 INCORRECT DOSE ADMINISTERED 5 0.0000
553 SUICIDAL IDEATION 2 0.0000
554 OROPHARYNGEAL PAIN 2 0.0000
555 SWELLING 2 0.0000
556 PRODUCT USE ISSUE 4 0.0000
557 ARRHYTHMIA 1 0.0000
558 PULMONARY EMBOLISM 2 0.0000
559 MIGRAINE 2 0.0000
560 PRODUCTIVE COUGH 1 0.0000
561 RASH ERYTHEMATOUS 1 0.0000
562 INFECTION 3 0.0000
563 INTERSTITIAL LUNG DISEASE 1 0.0000
564 LUNG DISORDER 1 0.0000
565 HYPOTENSION 4 0.0000
566 SINUSITIS 2 0.0000
567 HAEMOGLOBIN DECREASED 2 0.0000
568 PERIPHERAL SWELLING 3 0.0000
569 ERYTHEMA 4 0.0000
570 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
571 ABDOMINAL DISTENSION 2 0.0000
572 HAEMORRHAGE 2 0.0000
573 PLATELET COUNT DECREASED 2 0.0000
574 ASTHENIA 7 0.0000
575 DRUG EFFECT DECREASED 1 0.0000
576 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
577 OEDEMA 1 0.0000
578 HAEMATOCHEZIA 1 0.0000
579 MEDICATION ERROR 1 0.0000
580 INFLUENZA 2 0.0000
581 SEPSIS 2 0.0000
582 ABDOMINAL DISCOMFORT 3 0.0000
583 WEIGHT INCREASED 4 0.0000
584 OXYGEN SATURATION DECREASED 1 0.0000
585 CONVULSION 1 0.0000
586 PRODUCT SUBSTITUTION ISSUE 1 0.0000
587 PYREXIA 6 0.0000
588 SURGERY 1 0.0000
589 SUICIDE ATTEMPT 1 0.0000
590 LOSS OF CONSCIOUSNESS 2 0.0000
591 RHINORRHOEA 1 0.0000
592 AMNESIA 1 0.0000
593 PRODUCT DOSE OMISSION 1 0.0000
594 INFUSION RELATED REACTION 1 0.0000
595 FALL 5 0.0000
596 SOMNOLENCE 3 0.0000
597 ABDOMINAL PAIN UPPER 3 0.0000
598 MEMORY IMPAIRMENT 2 0.0000
599 COUGH 4 0.0000
600 SLEEP DISORDER 1 0.0000
601 SKIN BURNING SENSATION 1 0.0000
602 RASH 6 0.0000
603 UNDERDOSE 1 0.0000
604 AGITATION 1 0.0000
605 BRONCHITIS 1 0.0000
606 DYSGEUSIA 1 0.0000
607 EPISTAXIS 1 0.0000
608 HOSPITALISATION 2 0.0000
609 HEADACHE 8 0.0000
610 ARTHRITIS 1 0.0000
611 PARAESTHESIA 2 0.0000
612 DRUG DEPENDENCE 2 0.0000
613 THROMBOSIS 1 0.0000
614 TREMOR 2 0.0000
615 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
616 MYOCARDIAL INFARCTION 2 0.0000
617 INTENTIONAL PRODUCT MISUSE 1 0.0000
618 DRUG WITHDRAWAL SYNDROME 1 0.0000
619 GASTROINTESTINAL DISORDER 1 0.0000
620 MUSCLE SPASMS 2 0.0000
621 NASOPHARYNGITIS 2 0.0000
622 BLOOD GLUCOSE INCREASED 2 0.0000
623 DYSPNOEA 6 0.0000
624 DYSPHAGIA 1 0.0000
625 PRURITUS 4 0.0000
626 CONTUSION 1 0.0000
627 HEART RATE INCREASED 1 0.0000
628 SYNCOPE 1 0.0000
629 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
630 FLUSHING 1 0.0000
631 OVERDOSE 2 0.0000
632 PSORIASIS 1 0.0000
633 ARTHRALGIA 3 0.0000
634 MALAISE 3 0.0000
635 PAIN IN EXTREMITY 2 0.0000
636 BLOOD PRESSURE INCREASED 1 0.0000
637 CONFUSIONAL STATE 1 0.0000
638 URTICARIA 1 0.0000
639 CEREBROVASCULAR ACCIDENT 1 0.0000
640 MYALGIA 1 0.0000
641 URINARY TRACT INFECTION 1 0.0000
642 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
643 GAIT DISTURBANCE 1 0.0000
644 ALOPECIA 1 0.0000
645 INJECTION SITE PAIN 1 0.0000